Skip to main content

A Patient Presented with Extensive Lung Metastases of Papillary Thyroid Carcinoma Without Any Primary Focus Detected on Total Thyroidectomy

  • Chapter
  • First Online:
Thyroid and Parathyroid Diseases

Abstract

The most common metastatic sites of differentiated thyroid cancer (DTC) are the lung and bone after lymph nodes. A newly defined type of occult DTC is consistent with metastatic disease without an identified primary malignancy in the thyroid gland after total resection. We present a patient with multiple lung metastases of occult DTC showing mild 18F-fluorodeoxyglucose (FDG) uptake and intense radioiodine uptake without a primary lesion in the thyroid gland.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer. 2007;110:1451–6.

    Article  Google Scholar 

  2. Kalra R, Pawar R, Hasija S, Chandna A, Sankla M, Malhotra C. Frontal bone metastasis from an occult follicular thyroid carcinoma: diagnosed by FNAC. J Cytol. 2017;34:59–61.

    Article  Google Scholar 

  3. Liu H, Lv L, Yang K. Occult thyroid carcinoma: a rare case report and review of literature. Int J Clin Exp Pathol. 2014;7:5210–4.

    PubMed  PubMed Central  Google Scholar 

  4. Borsò E, Boni G, Mazzarri S, Cocciaro A, Gambacciani C, Traino AC, et al. Disseminated bone metastases from occult thyroid cancer effectively treated with debulking surgery and a single dosimetry-guided administration of radioiodine. Rev Esp Med Nucl Imagen Mol. 2015;34:111–5.

    PubMed  Google Scholar 

  5. Xu B, Scognamiglio T, Cohen PR, Prasad ML, Hasanovic A, Michael Tuttle R, et al. Metastatic thyroid carcinoma without identifiable primary tumor within the thyroid gland: a retrospective study of a rare phenomenon. Hum Pathol. 2017;65:133–9.

    Article  CAS  Google Scholar 

  6. Kaseda K, Watanabe K, Sakamaki H, Kazama A. Solitary pulmonary metastasis from occult papillary thyroid carcinoma. Thorac Cancer. 2016;7:261–3.

    Article  Google Scholar 

  7. Qutbi M, Shafeie B, Amoui M, Tabeie F, Azizmohammadi Z, Mahmoud-Pashazadeh A, et al. Evaluation of prognostic factors associated with differentiated thyroid carcinoma with pulmonary metastasis. Clin Nucl Med. 2016;41:917–21.

    Article  Google Scholar 

  8. Kim M, Kim WG, Park S, Kwon H, Jeon MJ, Lee JJ, et al. Initial size of metastatic lesions is best prognostic factor in patients with metastatic differentiated thyroid carcinoma confined to the lung. Thyroid. 2017;27:49–58.

    Article  CAS  Google Scholar 

  9. Song HJ, Qiu ZL, Shen CT, Wei WJ, Luo QY. Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors. Eur J Endocrinol. 2015;173:399–408.

    Article  CAS  Google Scholar 

  10. Wang R, Zhang Y, Tan J, Zhang G, Zhang R, Zheng W, et al. Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis: an 8-year retrospective study. Medicine (Baltimore). 2017;96:e6809. https://doi.org/10.1097/MD.0000000000006809.

    Article  CAS  Google Scholar 

  11. Biko J, Reiners C, Kreissl MC, Verburg FA, Demidchik Y, Drozd V. Favourable course of disease after incomplete remission on (131)I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up. Eur J Nucl Med Mol Imaging. 2011;38:651–5.

    Article  Google Scholar 

  12. Basu S, Parghane RV. Designing and developing PET-based precision model in thyroid carcinoma: the potential avenues for a personalized clinical care. PET Clin. 2017;12:27–37.

    Article  Google Scholar 

  13. Giraudet AL, Taïeb D. PET imaging for thyroid cancers: current status and future directions. Ann Endocrinol. 2017;78:38–42.

    Article  Google Scholar 

  14. Vrachimis A, Burg MC, Wenning C, Allkemper T, Weckesser M, Schäfers M. [(18)F]FDG PET/CT outperforms [(18)F]FDG PET/MRI in differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2016;43:212–20.

    Article  CAS  Google Scholar 

  15. Kim MS, Sim YS, Lee SY, Jeon DG. Occult thyroid carcinoma detected by FDG-PET scan in elderly osteosarcoma patients: report of two cases. Ann Nucl Med. 2007;21:529–32.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Çermik, T.F., Ergül, N. (2019). A Patient Presented with Extensive Lung Metastases of Papillary Thyroid Carcinoma Without Any Primary Focus Detected on Total Thyroidectomy. In: Özülker, T., Adaş, M., Günay, S. (eds) Thyroid and Parathyroid Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-78476-2_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-78476-2_30

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-78475-5

  • Online ISBN: 978-3-319-78476-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics